{"id":12301,"date":"2026-05-09T15:32:21","date_gmt":"2026-05-09T15:32:21","guid":{"rendered":"https:\/\/www.elbonifit.com\/?post_type=product&#038;p=12301"},"modified":"2026-05-09T18:00:54","modified_gmt":"2026-05-09T18:00:54","slug":"tirzepatide-glp-2-30-mg","status":"publish","type":"product","link":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg","title":{"rendered":"Tirzepatide GLP-2 30 mg"},"content":{"rendered":"<ul class=\"elementor-icon-list-items\">\n<li class=\"elementor-icon-list-item\"><span class=\"elementor-icon-list-text\">Physical profile: Lyophilized powder<\/span><\/li>\n<li class=\"elementor-icon-list-item\"><span class=\"elementor-icon-list-text\">This product is sold as a research chemical and not for human or animal consumption. For laboratory use by qualified professionals.<\/span><\/li>\n<li>No Returns accepted<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<div class=\"elementor-element elementor-element-707d759 elementor-widget__width-initial elementor-widget elementor-widget-accordion\" data-id=\"707d759\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"accordion.default\">\n<div class=\"elementor-widget-container\">\n<div class=\"elementor-accordion\">\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-content-1171\" class=\"elementor-tab-content elementor-clearfix elementor-active\" role=\"region\" data-tab=\"1\" aria-labelledby=\"elementor-tab-title-1171\">\n<h2>Buy GLP-2 (TRZ) 30mg Research Peptide Online<\/h2>\n<p>The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings.<\/p>\n<h3>Peptide Classification &amp; Molecular Properties<\/h3>\n<p>The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms &gt;98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes.<\/p>\n<h3>Mechanism of Action in Preclinical Models<\/h3>\n<p>Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa.<\/p>\n<h3>Published Research Summary<\/h3>\n<p>Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects.<\/p>\n<h3>Specifications &amp; Handling<\/h3>\n<p>Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions.<\/p>\n<h3>GLP-2 (TRZ) Research Use Only Disclaimer<\/h3>\n<p>For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies.<\/p>\n<\/div>\n<\/div>\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-title-1172\" class=\"elementor-tab-title\" role=\"button\" data-tab=\"2\" aria-controls=\"elementor-tab-content-1172\" aria-expanded=\"false\"><a class=\"elementor-accordion-title\" tabindex=\"0\">Protocol<\/a><\/div>\n<\/div>\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-title-1173\" class=\"elementor-tab-title\" role=\"button\" data-tab=\"3\" aria-controls=\"elementor-tab-content-1173\" aria-expanded=\"false\"><a class=\"elementor-accordion-title\" tabindex=\"0\">Clinical Research<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"elementor-element elementor-element-5f84297 elementor-product-loop-item--align-left elementor-grid-4 elementor-grid-tablet-3 elementor-grid-mobile-2 elementor-products-grid elementor-wc-products show-heading-yes elementor-widget elementor-widget-woocommerce-product-related\" data-id=\"5f84297\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"woocommerce-product-related.default\">\n<div class=\"elementor-widget-container\">\n<section class=\"related products\">\n<h2>Related products<\/h2>\n<\/section>\n<\/div>\n<\/div>\n","protected":false},"featured_media":12315,"comment_status":"open","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_joinchat":[]},"product_brand":[],"product_cat":[16],"product_tag":[],"class_list":["post-12301","product","type-product","status-publish","has-post-thumbnail","product_cat-uncategorized","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification &amp; Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms &gt;98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_ES\" \/>\n\t\t<meta property=\"og:site_name\" content=\"BONIFIT - BIENVENIDOS\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Tirzepatide GLP-2 30 mg - BONIFIT\" \/>\n\t\t<meta property=\"og:description\" content=\"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification &amp; Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms &gt;98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"831\" \/>\n\t\t<meta property=\"og:image:height\" content=\"833\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-09T15:32:21+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-09T18:00:54+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Tirzepatide GLP-2 30 mg - BONIFIT\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification &amp; Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms &gt;98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elbonifit.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"name\":\"TIENDA\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"position\":2,\"name\":\"TIENDA\",\"item\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"name\":\"Uncategorized\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"position\":3,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg#listItem\",\"name\":\"Tirzepatide GLP-2 30 mg\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"name\":\"TIENDA\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg#listItem\",\"position\":4,\"name\":\"Tirzepatide GLP-2 30 mg\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"ItemPage\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg#itempage\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg\",\"name\":\"Tirzepatide GLP-2 30 mg - BONIFIT\",\"description\":\"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification & Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms >98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\\\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications & Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\\u00b0C (standard), -80\\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products\",\"inLanguage\":\"es-ES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/IMG-20260509-WA0016.jpg\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg\\\/#mainImage\",\"width\":1235,\"height\":1060},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg#mainImage\"},\"datePublished\":\"2026-05-09T15:32:21+00:00\",\"dateModified\":\"2026-05-09T18:00:54+00:00\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#organization\",\"name\":\"BONIFIT\",\"description\":\"BIENVENIDOS\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cropped-bonifit.with-white-2.png\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg\\\/#organizationLogo\",\"width\":831,\"height\":833},\"image\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-30-mg\\\/#organizationLogo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/\",\"name\":\"BONIFIT\",\"description\":\"BIENVENIDOS\",\"inLanguage\":\"es-ES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Tirzepatide GLP-2 30 mg - BONIFIT","description":"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification & Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms >98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications & Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products","canonical_url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com#listItem","position":1,"name":"Home","item":"https:\/\/www.elbonifit.com","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","name":"TIENDA"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","position":2,"name":"TIENDA","item":"https:\/\/www.elbonifit.com\/?page_id=31","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","name":"Uncategorized"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","position":3,"name":"Uncategorized","item":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg#listItem","name":"Tirzepatide GLP-2 30 mg"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","name":"TIENDA"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg#listItem","position":4,"name":"Tirzepatide GLP-2 30 mg","previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","name":"Uncategorized"}}]},{"@type":"ItemPage","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg#itempage","url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg","name":"Tirzepatide GLP-2 30 mg - BONIFIT","description":"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification & Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms >98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications & Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products","inLanguage":"es-ES","isPartOf":{"@id":"https:\/\/www.elbonifit.com\/#website"},"breadcrumb":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2026\/05\/IMG-20260509-WA0016.jpg","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg\/#mainImage","width":1235,"height":1060},"primaryImageOfPage":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg#mainImage"},"datePublished":"2026-05-09T15:32:21+00:00","dateModified":"2026-05-09T18:00:54+00:00"},{"@type":"Organization","@id":"https:\/\/www.elbonifit.com\/#organization","name":"BONIFIT","description":"BIENVENIDOS","url":"https:\/\/www.elbonifit.com\/","logo":{"@type":"ImageObject","url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-2.png","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg\/#organizationLogo","width":831,"height":833},"image":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg\/#organizationLogo"}},{"@type":"WebSite","@id":"https:\/\/www.elbonifit.com\/#website","url":"https:\/\/www.elbonifit.com\/","name":"BONIFIT","description":"BIENVENIDOS","inLanguage":"es-ES","publisher":{"@id":"https:\/\/www.elbonifit.com\/#organization"}}]},"og:locale":"es_ES","og:site_name":"BONIFIT - BIENVENIDOS","og:type":"article","og:title":"Tirzepatide GLP-2 30 mg - BONIFIT","og:description":"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification &amp; Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms &gt;98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products","og:url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg","og:image":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png","og:image:secure_url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png","og:image:width":831,"og:image:height":833,"article:published_time":"2026-05-09T15:32:21+00:00","article:modified_time":"2026-05-09T18:00:54+00:00","twitter:card":"summary_large_image","twitter:title":"Tirzepatide GLP-2 30 mg - BONIFIT","twitter:description":"Buy GLP-2 (TRZ) 30mg Research Peptide Online The 30mg preparation provides research-grade capacity for investigating cumulative tissue adaptation responses and pharmacodynamic plateau effects. This concentration supports multi-week preclinical protocols examining intestinal remodeling trajectories and enteric neural plasticity in controlled laboratory settings. Peptide Classification &amp; Molecular Properties The GLP-2 (TRZ) agonist represents a peptide construct designed through structure-activity relationship studies optimizing potency and stability. Synthesis methodology incorporates automated solid-phase peptide chemistry with strategic incorporation of non-standard amino acids conferring enhanced metabolic stability. Chromatographic analysis confirms &gt;98% purity with pharmaceutical-grade handling throughout manufacturing and quality control processes. Mechanism of Action in Preclinical Models Research in laboratory animal systems demonstrates that GLP-2 receptor activation mediates intestinal epithelial proliferation through PI3K\/Akt signaling cascades. Immunohistochemical studies reveal increased labeling of proliferating cell nuclear antigen (PCNA) throughout intestinal crypts following agonist administration. These findings establish mechanistic linkage between receptor occupancy and enhanced epithelial regeneration capacity without affecting immune cell populations in underlying mucosa. Published Research Summary Simmonds et al. (Gastroenterology, 2002) characterized GLP-2 receptor expression and signal transduction in intestinal tissues, providing foundational mechanistic insights. Medhurst et al. (American Journal of Physiology, 2007) investigated sustained GLP-2 agonist administration in long-term animal protocols, documenting tissue adaptation trajectories. Contemporary preclinical literature confirms value of 30mg-scale studies for investigating duration-dependent intestinal remodeling effects. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 30mg; Solvent: Sterile water, PBS, or normal saline; Reconstitution: Ambient temperature dissolution over 20-30 minutes; Storage: -20\u00b0C (standard), -80\u00b0C (extended); Stability: 24 months under controlled storage conditions. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research Related products","twitter:image":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png"},"aioseo_meta_data":{"post_id":"12301","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"ItemPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2026-05-09 15:32:21","updated":"2026-05-18 05:04:14","ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\/?page_id=31\" title=\"TIENDA\">TIENDA<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\/?product_cat=uncategorized\" title=\"Uncategorized\">Uncategorized<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTirzepatide GLP-2 30 mg\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.elbonifit.com"},{"label":"TIENDA","link":"https:\/\/www.elbonifit.com\/?page_id=31"},{"label":"Uncategorized","link":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized"},{"label":"Tirzepatide GLP-2 30 mg","link":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-30-mg"}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12301"}],"version-history":[{"count":1,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12301\/revisions"}],"predecessor-version":[{"id":12303,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12301\/revisions\/12303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/media\/12315"}],"wp:attachment":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12301"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=12301"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=12301"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=12301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}